Arena Pharmaceuticals' (ARNA) Lorcaserin Proposed for DEA Schedule IV

December 18, 2012 9:47 AM EST Send to a Friend
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is seeing activity after its Lorcaserin was proposed for DEA Schedule IV placement. Link

The Drug Enforcement Administration (DEA) proposes placing the substance lorcaserin, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule IV of the Controlled Substances Act (CSA).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Trader Talk

Comments

You spelled proposed wrong
Matt on 2012-12-18 11:19:34
Mark as Spam | Reply to this comment

First comment.


Add Your Comment